By Adam Pick on June 12, 2013
Mike just sent me an interesting question about angina and coronary artery disease after valve surgery. In his note, Mike writes, “Hi Adam – I had an aortic valve replacement and double bypass in June 2004 by Dr. Joe Bavaria, Hospital University of Pennsylvania. Subsequently, I have been diagnosed with angina. I have also had several cardiac catheterizations and stents placed in the artery since my surgery. I understand that 10% of all stent and cardiac cath patients have recurrence of artery blockage. Do you know if anyone is doing research on this issue?
By Adam Pick on May 19, 2013
If you have not heard of transcatheter aortic valve implantation (TAVI), this post will introduce you to a breakthrough technology that recently received FDA approval for ‘inoperable’ and ‘high risk’ patients with severe aortic stenosis. If you have already heard of TAVI, the video below will provide you the latest update about TAVI from Dr. Michael Mack, a heart valve guru, a past-president of The Society of Thoracic Surgeons, and one of the clinical pioneers of TAVI at The Heart Hospital in Dallas, Texas — where he practices.
By Adam Pick on November 12, 2012
By Adam Pick on November 5, 2012
This Wednesday, November 7th, I am going to host a live, online webinar titled, “Advancements in Aortic Valve Surgery”with Dr. Davidson and Dr. Malaisrie from Northwestern Memorial Hospital.
By Adam Pick on November 2, 2012
Patient Webinar Announced: “Advancements in Aortic Valve Surgery” with Dr. Davidson, Dr. Malaisrie & Me
By Adam Pick on October 29, 2012
I am excited to announce that we will be hosting a Live Educational Webinar about the latest advancements in aortic valve surgery including transcatheter aortic valve implantation (TAVI). The webinar — which is free for all patients and caregivers — will be held on Wednesday, November 7 from 12pm-1pm CST.
By Adam Pick on October 24, 2012
As we continue to monitor the roll-out of transcatheter aortic valve implantation (TAVI) technologies, I just learned about a recent study for the CoreValve.
By Adam Pick on October 1, 2012
In case you missed it… The Sorin Group, a leading manufacturer of heart valve replacement devices, recently announced that its Perceval Sutureless Heart Valve Replacement device received a CE Mark for extended indications in Europe.
Tech Update: Medtronic Reaches Major Milestones For CoreValve Transcatheter Aortic Valve Replacement Device
By Adam Pick on September 5, 2012
As a technology enthusiast, I really enjoy monitoring the new devices impacting heart valve therapy.
By Adam Pick on July 20, 2012
As we continue to track and discuss the medical technologies that are impacting heart valve therapy, I just learned that Medtronic recently began patient enrollment in a unique study that will examine the performance of its CoreValve transcatheter aortic valve replacement device in ‘intermediate risk’ patients.